Andrew Berens
Stock Analyst at Leerink Partners
(1.17)
# 1963
Out of 5,370 analysts
222
Total ratings
51.49%
Success rate
2.01%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARVN Arvinas | Downgrades: Market Perform | 10 9 | 7.66 | 17.49% | 6 | Jun 2, 2025 | |
CMPX Compass Therapeutics | Upgrades: Outperform | 4 6 | 2.38 | 152.1% | 3 | Apr 2, 2025 | |
ELEV Elevation Oncology | Downgrades: Market Perform | 9 1 | n/a | n/a | 5 | Mar 21, 2025 | |
OKUR OnKure Therapeutics | Initiates Coverage On: Outperform | 33 | 2.62 | 1159.54% | 1 | Dec 5, 2024 | |
ZYME Zymeworks | Upgrades: Outperform | 10 25 | 12.54 | 99.36% | 10 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 74 96 | 109.27 | -12.14% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 60 56 | 35.34 | 58.46% | 11 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 5 3 | n/a | n/a | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 12.3 | 135.77% | 1 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | 50 97 | 128.18 | -24.33% | 24 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 69 110 | 76.28 | 44.21% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 78 | 70.43 | 10.75% | 12 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 78 58 | n/a | n/a | 7 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 48 | 53.01 | -9.45% | 5 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | n/a | n/a | 11 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 162 141 | n/a | n/a | 19 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 236 300 | n/a | n/a | 11 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 20 | 7.57 | 164.2% | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 28 | 11.83 | 136.69% | 3 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 79 | 72.44 | 9.06% | 12 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 27 | 1.48 | 1724.32% | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | 1.45 | 1968.97% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 69 | n/a | n/a | 4 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 101 76 | n/a | n/a | 6 | Jun 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 23 | n/a | n/a | 5 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 25 | 8.73 | 186.37% | 3 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 6.34 | 530.91% | 1 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | n/a | n/a | 1 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 67 | 1.61 | 4061.49% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 20 | 4.84 | 313.22% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 4.88 | 412.3% | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 16 | n/a | n/a | 5 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 3 | n/a | n/a | 6 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 2000 | n/a | n/a | 2 | Sep 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 156 146 | n/a | n/a | 3 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 102 18 | n/a | n/a | 2 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 75 50 | n/a | n/a | 5 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 8 | 8.65 | -7.51% | 7 | Jul 14, 2017 |